NCLAT: Consideration of Debt Restructuring by Lenders Doesn’t Bar Member from Initiating Proceedings  ||  Delhi High Court: In Matters of Medical Evaluation, Courts Should Exercise Restraint  ||  Delhi HC: Any Person in India Has Right to Legally Import Goods from Abroad and Sell the Same  ||  Delhi HC: Waiver to Section 12(5) of Arbitration Act to be Given Once Tribunal is Constituted  ||  Supreme Court Has Asked States to Regularise Existing Court Managers  ||  SC: Union & States to Create Special POSCO Courts on Top Priority  ||  SC Upholds Authority of CERC to Award Compensation for Delays  ||  SC: Arbitral Tribunal Has Discretion to Include in Sum Awarded, Interest at Rate as it Deems Reasonab  ||  SC: Cannot Use Article 142 to Frame Guidelines on Judicial Recusal  ||  SC: Satisfaction Recorder in One EP Won’t Affect Subsequent EPs for Future Breaches    

Hospira Books Indian Patent for ‘An Improved Process for the Preparation of Cilastatin’ - (19 Oct 2015)

US-based Hospira, now a subsidiary of pharma major Pfizer Inc, has secured an Indian patent for an improved process for preparation of Cilastatin -part of a medical compound used in the treatment of a number of bacterial infections.

Tags : HOSPIRA   PATENT  CILASTATIN  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved